Hyperglycemia induces memory impairment linked to increased acetylcholinesterase activity in zebrafish (Danio rerio)

Behavioural Brain Research

Volumn 274, Issue , 2014, Pages 319-325

  Capiotti, Katiucia Marques ^a   De Moraes, Daiani Almeida ^a   Menezes, Fabiano Peres ^a   Kist, Luiza Wilges ^a,b   Bogo, Maurício Reis ^a,b   Da Silva, Rosane Souza ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

Author keywords

Cholinergic system; Diabetes mellitus; Glucose; Hyperglycemia; Locomotor activity; Memory

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; GALANTAMINE; GLUCOSE; GLUCOSE TRANSPORTER 3; INSULIN RECEPTOR;

ANALYSIS OF VARIANCE; ANIMAL; AVOIDANCE BEHAVIOR; BRAIN; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; ESCAPE BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HYPERGLYCEMIA; MALE; MEMORY DISORDERS; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; ZEBRA FISH;

ACETYLCHOLINESTERASE; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BRAIN; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; ESCAPE REACTION; FEMALE; GALANTAMINE; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 3; HYPERGLYCEMIA; MALE; MEMORY DISORDERS; MOTOR ACTIVITY; RECEPTOR, INSULIN; ZEBRAFISH;

EID: 84908696190     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.08.033     Document Type: Article

References (53)

1. Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008, 29:494-511.
2. Chen Z., Zhong C. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 2013, 108:21-43.
3. Luchsinger J.A. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis 2012, 30.
4. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
5. McCall A.L. Cerebral glucose metabolism in diabetes mellitus. Eur J Pharmacol 2004, 490:147-158.
6. Aung M.H., Park H.N., Han M.K., Obertone T.S., Abey J., Aseem F., et al. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci 2014, 34:726-736.
7. Gardoni F., Kamal a, Bellone C., Biessels G.J., Ramakers G.M.J., Cattabeni F., et al. Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats. J Neurochem 2002, 80:438-447.
8. Elsherbiny N., Al-Gayyar M. Adenosine receptors new therapeutic targets for inflammation in diabetic nephropathy. Inflamm Allergy-Drug Targets 2013, 12:153-161.
9. Rivera E.J., Goldin A., Fulmer N., Tavares R., Wands J.R., de la Monte S.M. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis 2005, 8:247-268.
10. Sherin A., Anu J., Peeyush K.T., Smijin S., Anitha M., Roshni B.T., et al. Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats. Neuroscience 2012, 202:69-76.
11. Shaked I., Zimmerman G., Soreq H. Stress-induced alternative splicing modulations in brain and periphery: acetylcholinesterase as a case study. Ann NY Acad Sci 2008, 1148:269-281.
12. Sánchez-Chávez G., Salceda R. Effect of streptozotocin-induced diabetes on activities of cholinesterases in the rat retina. IUBMB Life 2000, 49:283-287.
13. Kuhad A., Chopra K. Lycopene ameliorates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rat. Indian J Exp Biol 2008, 46:108-111.
14. Olsen A.S., Sarras M.P., Intine R.V. Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus. Wound Repair Regen 2010, 18:532-542.
15. Gleeson M., Connaughton V., Arneson L.S. Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina. Acta Diabetol 2007, 44:157-163.
16. Capiotti K.M., Antonioli R., Kist L.W., Bogo M.R., Bonan C.D., Da Silva R.S. Persistent impaired glucose metabolism in a zebrafish hyperglycemia model. Comp Biochem Physiol B Biochem Mol Biol 2014, 171:58-65.
17. Schoel M. Instrumental learning in animals: parameters of reinforcement 1970, 1,2:2.
18. McGaugh J.L. Memory - a century of consolidation. Science 2000, 287:248-251.
19. Phelps H.A., Runft D.L., Neely M.N. Adult zebrafish model of streptococcal infection. Curr Protoc Microbiol 2009, Chapter 9: Unit 9D.1.
20. Blank M., Guerim L.D., Cordeiro R.F., Vianna M.R.M. A one-trial inhibitory avoidance task to zebrafish: rapid acquisition of an NMDA-dependent long-term memory. Neurobiol Learn Mem 2009, 92:529-534.
21. Gerlai R., Lahav M., Guo S., Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000, 67:773-782.
22. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
23. Rico E.P., Rosemberg D.B., Senger M.R., de Bem Arizi M., Bernardi G.F., Dias R.D., et al. Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain. Neurotoxicol Teratol 2006, 28:489-496.
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
25. Pereira V.M., Bortolotto J.W., Kist L.W., Azevedo M.B.de, Fritsch R.S., Oliveira R., da L., et al. Endosulfan exposure inhibits brain AChE activity and impairs swimming performance in adult zebrafish (Danio rerio). Neurotoxicology 2012, 33:469-475.
26. Tseng Y.-C., Chen R.-D., Lee J.-R., Liu S.-T., Lee S.-J., Hwang P.-P. Specific expression and regulation of glucose transporters in zebrafish ionocytes. Am J Physiol Regul, Integr Comp Physiol 2009, 297:R275-R290.
27. Toyoshima Y., Monson C., Duan C., Wu Y., Gao C., Yakar S., et al. The role of insulin receptor signaling in zebrafish embryogenesis. Endocrinology 2008, 149:5996-6005.
28. Tang R., Dodd A., Lai D., McNabb W.C., Love D.R. Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochim Biophys Sin 2007, 39:384-390.
29. Oggier D.M., Weisbrod C.J., Stoller A.M., Zenker A.K., Fent K. Effects of diazepam on gene expression and link to physiological effects in different life stages in zebrafish Danio rerio. Environ Sci Technol 2010, 44:7685-7691.
30. Nery L.R., Rodrigues M.M., Rosemberg D.B., Bogo M.R., De Farias C.B., Abujamra A.L., et al. Regulation of E-cadherin expression by growth factor receptors in cancer cells. J Surg Oncol 2011, 104:220-221.
31. Exalto L.G., Whitmer R.A., Kappele L.J., Biessels G.J. An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol 2012, 47:858-864.
32. Cox D.J., Kovatchev B.P., Gonder-Frederick L.A., Summers K.H., McCall A., Grimm K.J., et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 2005, 28:71-77.
33. Kanaya A.M., Barrett-Connor E., Gildengorin G., Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004, 164:1327-1333.
34. Yaffe K., Falvey C., Hamilton N., Schwartz A.V., Simonsick E.M., Satterfield S., et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012, 69:1170-1175.
35. Launer L.J., Miller M.E., Williamson J.D., Lazar R.M., Gerstein H.C., Murray A.M., et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011, 10:969-977.
36. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996, 45:1259-1266.
37. Kamal A., Biessels G., Hendrik W., Ramakers G.M.J. Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats. Brain Res 2006, 4:2-6.
38. Yin Q.-Q., Pei J.-J., Xu S., Luo D.-Z., Dong S.-Q., Sun M.-H., et al. Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats. PLOS ONE 2013, 8:e59313.
39. Hasselmo M.E. The role of acetylcholine in learning and memory. Curr Opin Neurobiol 2006, 16:710-715.
40. Deutsch J.A. The cholinergic synapse and the site of memory. Science (New York, NY) 1971, 174:788-794.
41. Yakel J.L. Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease. Pflugers Arch Eur J Physiol 2013, 465:441-450.
42. Pepeu G., Grazia M., Bracco L. effect of cholinesterase inhibitors on attention. Chem-Biol Interact 2013, 203:361-364.
43. Das A., Dikshit M., Nath C. Profile of acetylcholinesterase in brain areas of male and female rats of adult and old age. Life Sci 2001, 68:1545-1555.
44. Aldunate R., Casar J.C., Brandan E., Inestrosa N.C. Structural and functional organization of synaptic acetylcholinesterase. Brain Res Brain Res Rev 2004, 47:96-104.
45. Schmatz R., Mazzanti C.M., Spanevello R., Stefanello N., Gutierres J., Corrêa M., et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009, 610:42-48.
46. Mushtaq N., Schmatz R., Pereira L.B., Ahmad M., Stefanello N., Vieira J.M., et al. Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin-induced diabetic rats. Cell Biochem Funct 2014, 32:287-293.
47. Salgado H., Santos-Zavaleta A., Gama-Castro S., Millán-Zárate D., Díaz-Peredo E., Sánchez-Solano F., et al. RegulonDB (version 3.2): transcriptional regulation and operon organization in Escherichia coli K-12. Nucleic Acids Res 2001, 29:72-74.
48. Keseler I.M., Collado-Vides J., Gama-Castro S., Ingraham J., Paley S., Paulsen I.T., et al. EcoCyc: a comprehensive database resource for Escherichia coli. Nucleic Acids Res 2005, 33.
49. Thomsen T., Bickel U., Fischer J.P., Kewitz H. Stereoslectivity of cholinesterase inhibition by galanthamine and tolerance in humans. Eur J Clin Pharmacol 1990, 39:603-605.
50. Albuquerque E.X., Santos M.D., Alkondon M., Pereira E.F., Maelicke A. Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzheimer Dis Assoc Disord 2001, 15(Suppl. 1):S19-S25.
51. Maelicke A., Hoeffle-Maas A., Ludwig J., Maus A., Samochocki M., Jordis U., et al. Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy. J Mol Neurosci 2010, 40:135-137.
52. Samochocki M., Höffle A., Fehrenbacher A., Jostock R., Ludwig J., Christner C., et al. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J Pharmacol Exp Ther 2003, 305:1024-1036.
53. Traykova M., Traykov T., Hadjimitova V., Krikorian K., Bojadgieva N. Antioxidant properties of galantamine hydrobromide. Z Naturforsch/J Biosci 2003, 58:361-365.